Cynthia Frye Email & Phone Number

San Francisco Bay Area

Operationalized and accelerated registry and investigator-initiated study deliverables with cross-functional leaders and in collaboration with study teams across 2 North American corporate offices during COVID-19 pandemic. Managed transition from in office to remote and hybrid work environments through implementation of change-management strategies. Team included 3–6 direct reports plus contracted teams. • Achieved 2021 study goals with 1,000 patients enrolled by optimizing study start-up activities and evaluating multiple barriers during pandemic.• Reduced study turnaround times and improved resourcing requirements through collaboration with various leaders to implement research governance and strategic planning process.• Enabled clinical trial study teams to begin to scale efficiently via implementation of CTMS system, transitioning away from previously manual processes.

Salt Lake City Metropolitan Area

Managed shift to COVID-19 clinical trials and emergency-use designation during pandemic. Developed strategic approach to deliver high-visibility clinical trials for patients and partners, including Amgen, Genentech / Roche, and Bristol Myers Squibb Pharmaceuticals. Direct reports included 12-member oncology study team.• Decreased turnaround time for study start-up activities and increased patient enrollment by leveraging new technology within oncology and COVID-19 study teams.• Improved employee morale and productivity, as measured by employee-engagement surveys, through integration of oncology clinical trial study teams.

Salt Lake City Metropolitan Area

Promoted to lead teams across pharmaceutical-sponsored companion diagnostic clinical operations, publications office, and clinical research study auditing. Member of team charged with centralizing resources. Influenced executives across organization to approve current studies and publications faster by focusing on top reimbursement initiatives with evidence-based approaches. • Eliminated duplication in oncology, women’s health, autoimmune, neuroscience, dermatology, urology, in-DNA sequencing, RNA expression, and protein analysis biomarker technologies by setting priorities with leadership and restructuring governance.• Positioned evidence-based publications to support enterprise reimbursement goals through building comprehensive, high-level, clinical development portfolio.

Salt Lake City Metropolitan Area

Campaigned to launch new department focused on developing comprehensive scientific research review process and grew to team of 5. Supervised translation of scientific discoveries to research for peer-reviewed publications. Integrated published, peer-reviewed, relevant, scientific research into publications strategy. Collaborated with medical directors, chief medical officer, cross-functional teams, and executive leadership to prioritize programs and support publications. • Achieved higher than 42% employee engagement and ranked #2 in company after establishing team and aligning them with institutional objectives. • Grew publication program from 5 per year in 2005 to 100+ per year from 2015 as steward of 30 peer-reviewed publications and 80 professional presentations in 2017.• Delivered higher impact publications while reducing submission timeline and duplicated efforts by improving internal publications review process.

Salt Lake City Metropolitan Area

Senior Manager Clinical Research Program & PublicationsClinical Research Project Manager Clinical Research CoordinatorProfessional Support Specialist-Internal Genetic Counselor

New York City Metropolitan Area

Genetic counseling involving all hematologic conditions; pre-natal, pediatric, and adult clinics. Provided prenatal counseling two days a week for the Chinatown Health Clinic in Manhattan and Queens. Also, prenatal counseling for NYPH-Cornell patients cases included thalassemia, hemophilia, ultrasound findings, MSAFP, and AMA. Pediatric cases involving all hematological conditions and adult clinics for thalassemia screening. Research projects include investigation of thalassemia intermedia genotypes and phenotypes and insurance issues for hemophilia DNA studies. Supervised first year genetic counseling students.

Master Of Science - Ms, Genetic Counseling/Counselor

Bachelor Of Science - Bs, Health/Health Care Administration/Management